Eli Lilly Sub­poe­naed

The Washington Post - - National -

Eli Lilly said it re­ceived a sub­poena in Novem­ber from a U.S. grand jury in Penn­syl­va­nia seek­ing doc­u­ments in­volv­ing the mar­ket­ing of the com­pany’s best-sell­ing drug, the an­tipsy­chotic Zyprexa. It is co­op­er­at­ing in state and U.S. in­ves­ti­ga­tions into its mar­ket­ing prac­tices, ac­cord­ing to spokes­woman Marni Lemons.

Lemons’s state­ment also cited “many spec­u­la­tive state­ments” in a New York Times ar­ti­cle that said the drug­maker may pay more than $1 bil­lion to settle the in­ves­ti­ga­tion. “We reg­u­larly have dis­cus­sions with the gov­ern­ment,” Lemons said. She didn’t com­ment fur­ther on the Times ar­ti­cle.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.